Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKS3 encodes a scaffold protein characterized by ankyrin repeats and a sterile alpha motif (SAM) domain. This protein is predicted to function in the cytoplasm, localizing to cilia and potentially regulating cell polarity and ciliary movement. It is involved in complex formation with other nephronophthisis (NPH) proteins—such as ANKS6/NPHP16, Bicc1, and HIF1AN—and is essential for kidney development, functionality, and left–right patterning. Depletion or mutation of ANKS3 disrupts central metabolic pathways and nucleoside balance, leading to DNA damage responses and cell viability reduction; mutations in ANKS3 are causative of nephronophthisis and related ciliopathies as well as laterality defects in humans. While ANKS3 is not yet a direct drug target, it is a critical node in protein interaction networks underlying important developmental processes and diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat and sterile alpha motif domain-containing protein 3 (ANKS3).